Wujin Chen
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Pharmacological Effects of Natural Compounds
Papers in
-
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 3
-
- Gout, Hyperuricemia, Uric Acid 8
- Co-authors
- Yiyi Jin (5 shared papers)Jiumao Lin (7 shared papers)Jun Peng (3 shared papers)Jianyu Feng (3 shared papers)Zijun Lai (3 shared papers)Jiumao Lin (4 shared papers)Lisha Lu (4 shared papers)Jinyan Zhao (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Frontiers in Endocrinology (3 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)Scientific Reports (2 papers)ACS Pharmacology & Translational Science (1 paper)
- Partner nations
- ChinaUnited StatesGreece
In The Last Decade
Wujin Chen
32 papers receiving 301 citations
Peers
Comparison fields: 5 of 70
- Nephrology 45
- Pharmacology 24
- Cancer Research 29
- Oncology 52
- Pathology and Forensic Medicine 29
Countries citing papers authored by Wujin Chen
This map shows the geographic impact of Wujin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wujin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wujin Chen more than expected).
Fields of papers citing papers by Wujin Chen
This network shows the impact of papers produced by Wujin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wujin Chen. The network helps show where Wujin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wujin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 37 | |
| 2 | 2019 | 36 | |
| 3 | 2022 | 33 | |
| 4 | 2017 | 25 | |
| 5 | 2022 | 21 | |
| 6 | 2021 | 18 | |
| 7 | 2020 | 17 | |
| 8 | 2017 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2024 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2012 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 2 |
About Wujin Chen
Wujin Chen is a scholar working on Pulmonary and Respiratory Medicine, Nephrology, Molecular Biology, Oncology and Surgery, having authored 35 papers that have together received 305 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (8 papers), Gastric Cancer Management and Outcomes (4 papers), Phytochemistry and Bioactive Compounds (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Astrophysics and Star Formation Studies (2 papers), Gut microbiota and health (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Nephrology (45 citations), Pharmacology (24 citations), Cancer Research (29 citations), Oncology (52 citations) and Pathology and Forensic Medicine (29 citations). Wujin Chen has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Yiyi Jin, Jiumao Lin, Jun Peng, Jianyu Feng, Zijun Lai, Jiumao Lin, Lisha Lu, Jinyan Zhao, Hong Yang and Ling Zhang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Endocrinology, Anti-Cancer Agents in Medicinal Chemistry, Scientific Reports and ACS Pharmacology & Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.